Page last updated: 2024-10-28

hypericin and ATLL

hypericin has been researched along with ATLL in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Hypericin (HY) is a new-type of photosensitizer in the context of photodynamic therapy (PDT) due to its excellent photosensitizing properties and anti-tumor activities."1.51Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription. ( Cheng, W; Shao, L; Wang, Y; Wang, Z; Xu, L; Yi, K; Zhang, X; Zhang, Y; Zhao, T, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, L1
Zhang, X1
Cheng, W1
Wang, Y1
Yi, K1
Wang, Z1
Zhang, Y1
Shao, L1
Zhao, T1

Other Studies

1 other study available for hypericin and ATLL

ArticleYear
Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
    Retrovirology, 2019, 02-19, Volume: 16, Issue:1

    Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human T-lymphotropic vi

2019